BCL6: somatic mutations and expression in early-stage chronic lymphocytic leukemia. 2009

Eloisa Jantus Lewintre, and Cristina Reinoso Martín, and Carlos García Ballesteros, and Jehzabel Pendas, and Carmen Benet Campos, and José Ramón Mayans Ferrer, and Javier García-Conde
Molecular Haematology Laboratory, Prince Felipe Research Centre, Valencia, Spain. jantus_elo@gva.es

BCL6 somatic mutations affect normal and tumoral post germinal center B-lymphocytes. Our objective was to analyse expression, mutations and polymorphisms in the BCL6 gene and to correlate those variables with the clinical outcome in early-stage chronic lymphocytic leukemia (CLL). CLL samples were used for characterisation of the mutational status of BCL6/ immunoglobulin variable heavy chain (IGHV) genes, and expression of BCL6 was determined by real time PCR and immunoblot. Out of 68 cases, 29% show somatic mutations on BCL6 which occur exclusively in IGHV mutated cases. They are single nucleotide substitutions located mainly in two short mutational hot spots. CLL cells express different levels of BCL6 regardless of the mutational status, the number of mutations and polymorphisms. CLL cases expressing high levels of BCL6 have significantly shorter treatment-free interval. In conclusion, in early-stage patients with CLL, we found no correlation between expression and the mutations or polymorphism in BCL6, but high levels of BCL6 can discriminate patients with a worse prognosis.

UI MeSH Term Description Entries
D007143 Immunoglobulin Heavy Chains The largest of polypeptide chains comprising immunoglobulins. They contain 450 to 600 amino acid residues per chain, and have molecular weights of 51-72 kDa. Immunoglobulins, Heavy-Chain,Heavy-Chain Immunoglobulins,Ig Heavy Chains,Immunoglobulin Heavy Chain,Immunoglobulin Heavy Chain Subgroup VH-I,Immunoglobulin Heavy Chain Subgroup VH-III,Heavy Chain Immunoglobulins,Heavy Chain, Immunoglobulin,Heavy Chains, Ig,Heavy Chains, Immunoglobulin,Immunoglobulin Heavy Chain Subgroup VH I,Immunoglobulin Heavy Chain Subgroup VH III,Immunoglobulins, Heavy Chain
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009154 Mutation Any detectable and heritable change in the genetic material that causes a change in the GENOTYPE and which is transmitted to daughter cells and to succeeding generations. Mutations
D011110 Polymorphism, Genetic The regular and simultaneous occurrence in a single interbreeding population of two or more discontinuous genotypes. The concept includes differences in genotypes ranging in size from a single nucleotide site (POLYMORPHISM, SINGLE NUCLEOTIDE) to large nucleotide sequences visible at a chromosomal level. Gene Polymorphism,Genetic Polymorphism,Polymorphism (Genetics),Genetic Polymorphisms,Gene Polymorphisms,Polymorphism, Gene,Polymorphisms (Genetics),Polymorphisms, Gene,Polymorphisms, Genetic
D011237 Predictive Value of Tests In screening and diagnostic tests, the probability that a person with a positive test is a true positive (i.e., has the disease), is referred to as the predictive value of a positive test; whereas, the predictive value of a negative test is the probability that the person with a negative test does not have the disease. Predictive value is related to the sensitivity and specificity of the test. Negative Predictive Value,Positive Predictive Value,Predictive Value Of Test,Predictive Values Of Tests,Negative Predictive Values,Positive Predictive Values,Predictive Value, Negative,Predictive Value, Positive
D011379 Prognosis A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations. Prognostic Factor,Prognostic Factors,Factor, Prognostic,Factors, Prognostic,Prognoses
D004268 DNA-Binding Proteins Proteins which bind to DNA. The family includes proteins which bind to both double- and single-stranded DNA and also includes specific DNA binding proteins in serum which can be used as markers for malignant diseases. DNA Helix Destabilizing Proteins,DNA-Binding Protein,Single-Stranded DNA Binding Proteins,DNA Binding Protein,DNA Single-Stranded Binding Protein,SS DNA BP,Single-Stranded DNA-Binding Protein,Binding Protein, DNA,DNA Binding Proteins,DNA Single Stranded Binding Protein,DNA-Binding Protein, Single-Stranded,Protein, DNA-Binding,Single Stranded DNA Binding Protein,Single Stranded DNA Binding Proteins
D005260 Female Females
D005803 Genes, Immunoglobulin Genes encoding the different subunits of the IMMUNOGLOBULINS, for example the IMMUNOGLOBULIN LIGHT CHAIN GENES and the IMMUNOGLOBULIN HEAVY CHAIN GENES. The heavy and light immunoglobulin genes are present as gene segments in the germline cells. The completed genes are created when the segments are shuffled and assembled (B-LYMPHOCYTE GENE REARRANGEMENT) during B-LYMPHOCYTE maturation. The gene segments of the human light and heavy chain germline genes are symbolized V (variable), J (joining) and C (constant). The heavy chain germline genes have an additional segment D (diversity). Genes, Ig,Immunoglobulin Genes,Gene, Ig,Gene, Immunoglobulin,Ig Gene,Ig Genes,Immunoglobulin Gene

Related Publications

Eloisa Jantus Lewintre, and Cristina Reinoso Martín, and Carlos García Ballesteros, and Jehzabel Pendas, and Carmen Benet Campos, and José Ramón Mayans Ferrer, and Javier García-Conde
November 2017, Leukemia & lymphoma,
Eloisa Jantus Lewintre, and Cristina Reinoso Martín, and Carlos García Ballesteros, and Jehzabel Pendas, and Carmen Benet Campos, and José Ramón Mayans Ferrer, and Javier García-Conde
January 2009, Cytotherapy,
Eloisa Jantus Lewintre, and Cristina Reinoso Martín, and Carlos García Ballesteros, and Jehzabel Pendas, and Carmen Benet Campos, and José Ramón Mayans Ferrer, and Javier García-Conde
July 2011, Cancer cell,
Eloisa Jantus Lewintre, and Cristina Reinoso Martín, and Carlos García Ballesteros, and Jehzabel Pendas, and Carmen Benet Campos, and José Ramón Mayans Ferrer, and Javier García-Conde
February 1987, Cancer,
Eloisa Jantus Lewintre, and Cristina Reinoso Martín, and Carlos García Ballesteros, and Jehzabel Pendas, and Carmen Benet Campos, and José Ramón Mayans Ferrer, and Javier García-Conde
June 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology,
Eloisa Jantus Lewintre, and Cristina Reinoso Martín, and Carlos García Ballesteros, and Jehzabel Pendas, and Carmen Benet Campos, and José Ramón Mayans Ferrer, and Javier García-Conde
May 1997, Archives of pathology & laboratory medicine,
Eloisa Jantus Lewintre, and Cristina Reinoso Martín, and Carlos García Ballesteros, and Jehzabel Pendas, and Carmen Benet Campos, and José Ramón Mayans Ferrer, and Javier García-Conde
May 2017, JAMA internal medicine,
Eloisa Jantus Lewintre, and Cristina Reinoso Martín, and Carlos García Ballesteros, and Jehzabel Pendas, and Carmen Benet Campos, and José Ramón Mayans Ferrer, and Javier García-Conde
January 2016, Oncology research and treatment,
Eloisa Jantus Lewintre, and Cristina Reinoso Martín, and Carlos García Ballesteros, and Jehzabel Pendas, and Carmen Benet Campos, and José Ramón Mayans Ferrer, and Javier García-Conde
May 2012, The New England journal of medicine,
Eloisa Jantus Lewintre, and Cristina Reinoso Martín, and Carlos García Ballesteros, and Jehzabel Pendas, and Carmen Benet Campos, and José Ramón Mayans Ferrer, and Javier García-Conde
March 2008, Cancer,
Copied contents to your clipboard!